Announcements


06.Nov.26Ladas & Parry is pleased to announce that the firm has been recognized in the 2027 edition of...

06.Nov.26Ladas & Parry is pleased to share that Frank Gao, Patent Attorney in the firm’s Chicago...

06.Nov.26David Brezina, Of Counsel, is scheduled to participate in a panel discussion “What’s...

22.Oct.26Ladas & Parry Partner Sebastian Lovera will be attending ASIPI Santiago de Chile November 29th...

View all Announcements »


ladas-brochure-download

  • In re Peterson involved an appeal from the USPTO Board of Appeals with respect to the patentability of the claims of a pending US patent...

    Details Share b
  • This is a complex case involving a non-naturally occurring erythropoietin-glycoprotein product having a defined in vivo biological activity and having glycosylation which differs from that of human urinary...

    Details Share b
  • This was a Paragraph IV certification case filed after Novopharm filed an ANDA to market a generic form of fenofibrate prior to expiration of the relevant...

    Details Share b
  • The invention related to the isolation of the virus that caused “Mystery swine disease” (a.k.a Porcine Reproductive Respiratory Syndrome – PRRS). The claim was directed to growing and isolating a particular virus. The alleged infringement...

    Details Share b